Authors:
MULLER BW
RAO ML
HENNING U
SARTORY G
BENDER S
OADES RD
Citation: Bw. Muller et al., PLASMA DOPAMINE ACTIVITY, DA-D2 BINDING, NEUROPSYCHOLOGICAL SIGNS ANDCONDITIONED BLOCKING (CB) IN SCHIZOPHRENIA, European journal of neuroscience, 10, 1998, pp. 14702-14702
Authors:
BENDER S
MULLER B
RAO ML
HENNING U
SARTORY G
FINKBEINER T
OADES RD
Citation: S. Bender et al., PLASMA DOPAMINE (DA) ACTIVITY, DA-D2 BINDING, NEUROPSYCHOLOGICAL SIGNS AND CONDITIONED BLOCKING (CB) IN SCHIZOPHRENIA, Schizophrenia research, 29(1-2), 1998, pp. 53-54
Authors:
RODEWALD S
MULLER B
OADES RD
HENNING U
RAO ML
BENDER S
WOLSTEIN J
Citation: S. Rodewald et al., PLASMA INDICATORS OF MONOAMINE METABOLISM AND NICOTINE CONSUMPTION - A FACTOR AND CORRELATIONAL ANALYSIS WITH SCHIZOPHRENIC SYMPTOM CLUSTERS, Schizophrenia research, 29(1-2), 1998, pp. 95-95
Authors:
RAO ML
HAWELLEK B
PAPASSOTIROPOULOS A
DEISTER A
FRAHNERT C
Citation: Ml. Rao et al., UP-REGULATION OF THE PLATELET SEROTONIN(2A) RECEPTOR AND LOW BLOOD SEROTONIN IN SUICIDAL PSYCHIATRIC-PATIENTS, Neuropsychobiology, 38(2), 1998, pp. 84-89
Authors:
BAGLI M
PAPASSOTIROPOULOS A
FEDER O
SCHWAB S
LUDWIG M
RAO ML
JESSEN F
MAIER W
HEUN R
Citation: M. Bagli et al., PCR-RFLP ANALYSIS OF GENES INVOLVED IN AMYLOID PRECURSOR PROTEIN (APP) PROCESSING - AN ASSOCIATION STUDY TO ELUCIDATE THE IMPLICATIONS FOR ALZHEIMERS-DISEASE, American journal of medical genetics, 81(6), 1998, pp. 555-555
Authors:
PAPASSOTIROPOULOS A
BAGLI M
JESSEN F
SCHWAB S
RAO ML
MAIER W
HEUN R
Citation: A. Papassotiropoulos et al., VARIABLE NUMBER TANDEM REPEAT (VNTR) POLYMORPHISM OF THE INTERLEUKIN-6 GENE IN ALZHEIMERS-DISEASE - AN ASSOCIATION STUDY, American journal of medical genetics, 81(6), 1998, pp. 555-556
Authors:
PAPASSOTIROPOULOS A
BAGLI M
JESSEN F
SCHWAB S
RAO ML
MAIER W
HEUN R
Citation: A. Papassotiropoulos et al., THE CONTRIBUTION OF AN INTRONIC POLYMORPHISM OF THE PRESENILIN-1 GENETO THE FAMILIAL AGGREGATION OF ALZHEIMERS-DISEASE, American journal of medical genetics, 81(6), 1998, pp. 555-555
Authors:
RAO ML
PAPASSOTIROPOULOS A
HAWELLEK B
FRAHNERT C
Citation: Ml. Rao et al., SUICIDAL PSYCHIATRIC-INPATIENTS HAVE LOW PLASMA-CHOLESTEROL AND LOW BLOOD SEROTONIN, Biological psychiatry, 43, 1998, pp. 350-350
Citation: M. Bagli et al., DETERMINATION OF FLUVOXAMINE AND PAROXETINE IN HUMAN SERUM WITH HIGHPERFORMANCE LIQUID-CHROMATOGRAPHY AND ULTRAVIOLET DETECTION, Journal of liquid chromatography & related technologies, 20(2), 1997, pp. 283-295
Authors:
SCHLOSSER R
SCHLEGEL S
HIEMKE C
NICKEL O
BOCKISCH A
RAO ML
HAHN K
Citation: R. Schlosser et al., [I-123] IBZM SPECT IN PATIENTS TREATED WITH TYPICAL AND ATYPICAL NEUROLEPTICS - RELATIONSHIP TO DRUG PLASMA-LEVELS AND EXTRAPYRAMIDAL SIDE-EFFECTS, PSYCHIATRY RESEARCH-NEUROIMAGING, 75(2), 1997, pp. 103-114
Authors:
NEUMEISTER A
PRASCHAKRIEDER N
HESSELMANN B
RAO ML
GLUCK J
KASPER S
Citation: A. Neumeister et al., EFFECTS OF TRYPTOPHAN DEPLETION ON DRUG-FREE PATIENTS WITH SEASONAL AFFECTIVE-DISORDER DURING A STABLE RESPONSE TO BRIGHT LIGHT THERAPY, Archives of general psychiatry, 54(2), 1997, pp. 133-138
Authors:
BAGLI M
HOFLICH G
RAO ML
LANGER M
BAUMANN P
KOLBINGER M
BARLAGE U
KASPER S
MOLLER HJ
Citation: M. Bagli et al., BIOEQUIVALENCE AND ABSOLUTE BIOAVAILABILITY OF LEVOMEPROMAZINE OBLONGAND COATED TABLETS IN CYP2D6 PHENOTYPED SUBJECTS (VOL 33, PG 646, 1995), International journal of clinical pharmacology and therapeutics, 34(2), 1996, pp. 92-92
Citation: Hj. Assion et al., LYMPHOCYTOPENIA AND THROMBOCYTOPENIA DURING TREATMENT WITH RISPERIDONE OR CLOZAPINE, Pharmacopsychiatry, 29(6), 1996, pp. 227-228
Authors:
RAO ML
RUHRMANN S
RETEY B
LIAPPIS N
FUGER J
KRAEMER M
KASPER S
MOLLER HJ
Citation: Ml. Rao et al., LOW PLASMA THYROID INDEXES OF DEPRESSED-PATIENTS ARE ATTENUATED BY ANTIDEPRESSANT DRUGS AND INFLUENCE TREATMENT OUTCOME, Pharmacopsychiatry, 29(5), 1996, pp. 180-186
Authors:
RAO ML
DEISTER A
LAUX G
STABEROCK U
HOFLICH G
MOLLER HJ
Citation: Ml. Rao et al., LOW SERUM LEVELS OF TRICYCLIC ANTIDEPRESSANTS IN AMITRIPTYLINE-TREATED AND DOXEPIN-TREATED INPATIENTS WITH DEPRESSIVE SYNDROMES ARE ASSOCIATED WITH NONRESPONSE, Pharmacopsychiatry, 29(3), 1996, pp. 97-102
Citation: M. Bagli et al., MEAN INPUT TIMES OF 3 ORAL CHLORPROTHIXENE FORMULATIONS ASSESSED BY AN ENHANCED LEAST-SQUARES DECONVOLUTION METHOD, Journal of pharmaceutical sciences, 85(4), 1996, pp. 434-439
Authors:
BAGLI M
RAO ML
HOFLICH G
KASPER S
LANGER M
BARLAGE U
BENEKE M
SUVERKRUP R
MOLLER HJ
Citation: M. Bagli et al., PHARMACOKINETICS OF CHLORPROTHIXENE AFTER SINGLE INTRAVENOUS AND ORAL-ADMINISTRATION OF 3 GALENIC PREPARATIONS, Arzneimittel-Forschung, 46(3), 1996, pp. 247-250
Authors:
BAGLI M
HOFLICH G
RAO ML
LANGER M
BAUMANN P
KOLBINGER M
BARLAGE U
KASPER S
MOLLER HJ
Citation: M. Bagli et al., BIOEQUIVALENCE AND ABSOLUTE BIOAVAILABILITY OF OBLONG AND COATED LEVOMEPROMAZINE TABLETS IN CYP2D6 PHENOTYPED SUBJECTS, International journal of clinical pharmacology and therapeutics, 33(12), 1995, pp. 646-652
Authors:
RAO ML
STREBEL B
HALARIS A
GROSS G
BRAUNIG P
HUBER G
MARLER M
Citation: Ml. Rao et al., CIRCADIAN-RHYTHM OF VITAL SIGNS, NOREPINEPHRINE, EPINEPHRINE, THYROID-HORMONES, AND CORTISOL IN SCHIZOPHRENIA, Psychiatry research, 57(1), 1995, pp. 21-39
Citation: M. Bagli et al., QUANTIFICATION OF CHLORPROTHIXENE, LEVOMEPROMAZINE AND PROMETHAZINE IN HUMAN SERUM USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH COULOMETRIC ELECTROCHEMICAL DETECTION, Journal of chromatography B. Biomedical applications, 657(1), 1994, pp. 141-148
Citation: Ml. Rao et Hj. Moller, BIOCHEMICAL FINDINGS OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND THEIR PUTATIVE RELEVANCE TO PHARMACOLOGICAL TREATMENT - A REVIEW, Neuropsychobiology, 30(4), 1994, pp. 160-172
Citation: Ml. Rao et al., AUTOAGGRESSIVE BEHAVIOR IS CLOSELY-RELATED TO SEROTONIN AVAILABILITY IN SCHIZOAFFECTIVE DISORDER, Pharmacopsychiatry, 27(5), 1994, pp. 202-206